- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05303779
Exercise Interventions for Improving Eye Control Post Strabismus Surgery
Exercise Interventions of Eye Muscles for Improving Eye Control Post Strabismus Surgery
The purpose of this study will be focused on the following issue:
1. The aim of this study is to determine therapeutic effect of postoperative eye exercises on improving eye control after the strabismus surgery.
HYPOTHESES:
It will be hypothesized that:
• Eye exercises have a positive effect on improving eye control post strabismus surgery.
RESEARCH QUESTION:"
• Do postoperative eye exercises improve eye control post strabismus surgery?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Therapeutic procedures:
- Patient will be informed about measurement and treatment procedure before beginning of the treatment.
- Patient will be asked to follow physician instructions.
- Patients will be asked to avoid participation in any rehabilitation program prior to the study which may affect the result of the study.
- Measurement procedures will be applied for each patient.
- They will start the treatment program after 2 weeks of the surgery.
The subjects will be divided into two groups (experimental group and control group) with equal numbers of patients in each group:
Control group Participants within the control group will receive traditional care and medication following strabismus surgery.
Experimental group Participants within the experimental group will receive physiotherapy exercises beside traditional care and medication after strabismus surgery. Physical therapy exercises will apply in the office and home. Office exercises will involve palming exercise, pencil push-ups, brock string exercise, thumb exercise (Near-distance jump), balance board exercise, Proprioceptors Neuromuscular Facilitating (PNF) exercise, occlusive therapy, eye hand coordination and computer therapy. Office exercises will be done two sessions per week for three months. Each session will be about 1 hour. Exercises will also perform at home from the first session including eye exercises in all directions, pencil push-ups, thumb exercise (Near-distance jump),brock string exercise, and dominant eye occlusion for 1 hour daily.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- Cairo University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Criteria of selecting the patients include the following:
- Patients are both males and females.
- Their age will range from (5-15) years.
- Patients received strabismus operation.
- They will be selected from Outpatient Clinic of Research Institute of Ophthalmology.
- Patients will begin the training program after 2 weeks of operation.
- All types of strabismus surgery will be included.
Exclusion Criteria:
The subjects will be excluded from the study if they meet one of the following criteria;
- Muscular disorders that will impair performance during training.
- Any organic lesion in the eye.
- Neurological disorders.
- Malignant conditions.
- Psychiatric illness, severe behavior or cognitive disorders.
- Children who can't understand the therapist's instructions and orders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: experimental group
experimental group will receive eye exercises in addition to medication and eye glasses post strabismus surgery
|
Application of eye exercise for improving eye control post strabismus surgery
Other Names:
medication and eye glasses used post strabismus surgery
Other Names:
|
|
ACTIVE_COMPARATOR: control group
control group will receive medication and eye glasses post strabismus surgery
|
medication and eye glasses used post strabismus surgery
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
changing in eye control
Time Frame: before the treatment and after 12 weeks (at the end of the treatment period )
|
The level of control will be evaluated in each patient at both distance and near fixation using Intermittent Exotropia Control Scale. Fixation targets will be at 3 meters for distance fixation and it will be at 33 centimeters for near fixation. Intermittent Exotropia Control Scale 5 = Constant exotropia 4 = Exotropia > 50% of the exam before dissociation 3 = Exotropia < 50% of the exam before dissociation 2 = No exotropia unless dissociated, recovers in > 5 seconds 1 = No exotropia unless dissociated, recovers in 1-5 seconds 0 = No exotropia unless dissociated, recovers in < 1 second (phoria) The scale ranges from 0 (phoria, best control) to 5 (constant exotropia, worst control). |
before the treatment and after 12 weeks (at the end of the treatment period )
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Amany Abdel Wahid, PhD, Lecturer
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/003505
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.